Clasificación en acciones
#33864
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company... 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Precio por acción
$0.5475
Última sincronización: 2026-08-14
Capitalización bursátil
$6.71M
Comercio 20/20 Biolabs Inc. (AIDX)
Precio AIDX con Capital del mercado a B
Capitalización de mercado de 20/20 Biolabs Inc.(AIDX)
Capitalización bursátil: $6.71M
A fecha de August 2026, 20/20 Biolabs Inc. tiene una capitalización de mercado de $6.71M. Esto convierte a 20/20 Biolabs Inc. en la 33864th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de 20/20 Biolabs Inc. desde 2026 hasta 2026
AIDX en comparación con los más populares 5 títulos stocks
| Precio por AIDX |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.452T
|
+81,276,656.64%
|
|
|
|
|
$4.490T
|
+66,937,378.02%
|
|
|
|
|
$4.162T
|
+62,053,302.40%
|
|
|
|
|
$3.676T
|
+54,807,023.79%
|
|
|
|
|
$2.833T
|
+42,235,061.84%
|
